These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3247742)

  • 21. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum ferritin in patients with chronic kidney failure. II].
    Galajdová E; Danko M; Holan J; Peterková M; Funiaková S; Hendrich F; Levcík A; Záhradný V
    Vnitr Lek; 1986 Sep; 32(9):851-4. PubMed ID: 3765423
    [No Abstract]   [Full Text] [Related]  

  • 23. Comment on: does zinc supplementation affect inflammatory markers in hemodialysis patients?
    Roozbeh J; Sharifian M; Sagheb MM; Shabani S; Hamidian Jahromi A; Afshariani R; Pakfetrat M; Salehi O
    Ren Fail; 2011; 33(4):466-7. PubMed ID: 21529280
    [No Abstract]   [Full Text] [Related]  

  • 24. [Iron reserves in patients with chronic renal insufficiency].
    Shostka GD
    Ter Arkh; 1987; 59(8):97-102. PubMed ID: 3686452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
    Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
    J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low serum albumin and high ferritin levels in chronic hemodialysis patients with major depression.
    Huang TL; Lee CT
    Psychiatry Res; 2007 Aug; 152(2-3):277-80. PubMed ID: 17445909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Iron metabolism in patients in kidney failure dialysis treatment].
    Zadrazil J; Bachleda P; Papajík T; Scudla V; Zahálková J; Budíková M; Novotný D
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():95-7. PubMed ID: 7976690
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of hemodialysis on the ATP blood level in patients with chronic kidney failure treated with hemodialysis].
    Caban M; Smoleński O; Barylak H; Kutrzeba W
    Pol Tyg Lek; 1977 Aug; 32(35):1369. PubMed ID: 896592
    [No Abstract]   [Full Text] [Related]  

  • 31. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis.
    Bradran A; Nasri H
    J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of hemodialysis on serum levels of glycocholic acid in patients with chronic renal failure].
    Kowalski D; Starzyk J; Kowalska K
    Wiad Lek; 1987 Dec; 40(23):1585-7. PubMed ID: 3451586
    [No Abstract]   [Full Text] [Related]  

  • 33. [Products of lipid peroxidation in the blood plasma of patients with chronic renal insufficiency treated with hemodialysis].
    Nikiforova NV; Sokolovskaia IV
    Ter Arkh; 1980; 52(4):55-7. PubMed ID: 7404338
    [No Abstract]   [Full Text] [Related]  

  • 34. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum ferritin and bone marrow iron in non-dialysis, peritoneal dialysis and hemodialysis patients with chronic renal failure.
    Milman N; Christensen TE; Pedersen NS; Visfeldt J
    Acta Med Scand; 1980; 207(3):201-5. PubMed ID: 7368987
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.
    Falaknazi K; Bagheri N; Taziki O
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):219-22. PubMed ID: 19237807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in the levels of various trace elements in the blood of patients with chronic renal failure treated by repeat hemodialysis and in disorders of peripheral motor conductivity].
    Weyde W; Adamiec R; Rudkowska A
    Przegl Lek; 1987; 44(4):397-9. PubMed ID: 2819955
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of hemodialysis and hemofiltration on the serum beta-2 microglobulin content of patients kept on chronic hemodialysis regimen (author's transl)].
    Prejac M; Mikulicic V; Jeren-Struić B; Kozjak D
    Lijec Vjesn; 1980; 102(7-8):386-91. PubMed ID: 6169969
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of hemodialysis on blood hormone and lipid levels in patients with chronic kidney failure].
    Dzhavad-Zade MD; Agaev MM; Agabalaeva LI; Karaev ME; Movla-Zade NG
    Med Radiol (Mosk); 1987 Feb; 32(2):18-20. PubMed ID: 3807717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum ferritin concentration in patients receiving maintenance hemodialysis.
    Lynn KL; Mitchell TR; Shepperd J
    Clin Nephrol; 1980 Sep; 14(3):124-7. PubMed ID: 7418278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.